MDPC-857
Alternative Names: MDP-C857Latest Information Update: 12 Aug 1998
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Macrophage stimulants; Monocyte stimulants; Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 12 Aug 1998 Profile reviewed
- 12 Aug 1998 No-Development-Reported for Cancer in Poland (Unknown route)
- 12 Aug 1998 No-Development-Reported for Cancer in USA (Unknown route)